BRIEF published on 11/07/2024 at 11:53, 1 year ago ELARIS AG Appoints Steffen Cost as Chief Commercial Officer to Foster Growth Automotive Industry International Growth E-mobility ELARIS AG Steffen Cost
PRESS RELEASE published on 11/07/2024 at 11:48, 1 year ago ELARIS AG strengthens internal structures to enable further growth / Steffen Cost named Chief Commercial Officer (CCO) ELARIS AG appoints Steffen Cost as Chief Commercial Officer to strengthen internal structures for international growth Chief Commercial Officer International Growth ELARIS AG Steffen Cost Internal Structures
BRIEF published on 10/10/2024 at 09:35, 1 year 1 month ago ELARIS AG Considers Offshoring to Counter EU Tariffs Electric Cars ELARIS AG Offshoring EU Tariffs SKD Production
PRESS RELEASE published on 10/10/2024 at 09:30, 1 year 1 month ago ELARIS AG is considering the possibility of offshoring SKD production in response to the threat of punitive EU tariffs ELARIS AG considers offshoring SKD production to avoid EU tariffs on Chinese e-cars, in talks with potential partners from three countries ELARIS AG Offshoring EU Tariffs SKD Production E-cars
BRIEF published on 09/24/2024 at 10:35, 1 year 2 months ago ELARIS AG: Kiesel Group's Investment Opens Up Strategic Business Potential Innovation Construction Industry Electric Vehicles Strategic Partnership Investment
PRESS RELEASE published on 09/24/2024 at 10:30, 1 year 2 months ago ELARIS AG: Kiesel Group's investment opens up strategic business potential ELARIS AG's partnership with Kiesel Group aims to boost strategic business opportunities in electrification of construction vehicles, supported by Kiesel's expertise and investment Electrification Investment ELARIS AG Kiesel Group Strategic Business Potential
BRIEF published on 09/17/2024 at 09:19, 1 year 2 months ago ELARIS AG Achieves First Positive Operating Result in H1 2024 Revenue Growth Electric Vehicles Operating Profit ELARIS 2024 Results
PRESS RELEASE published on 09/17/2024 at 09:14, 1 year 2 months ago ELARIS AG posts its first positive operating result in the first half of 2024 and grows dynamically ELARIS AG achieves its first positive operating result in the first half of 2024, with sales revenues growing dynamically and significant further growth expected for the full year 2024 Growth ELARIS AG Sales Revenues Positive Operating Result
BRIEF published on 08/23/2024 at 18:25, 1 year 3 months ago ELARIS AG: Annual General Meeting Approves All Agenda Items with a Clear Majority Growth Strategy Annual General Meeting Shareholders International Expansion ELARIS AG
PRESS RELEASE published on 08/23/2024 at 18:20, 1 year 3 months ago ELARIS AG: Annual General Meeting approves all agenda items with a clear majority ELARIS AG shareholders approve all agenda items with a 97.6% majority at Annual General Meeting, focusing on growth strategy and international expansion Growth Strategy Annual General Meeting International Expansion ELARIS AG Agenda Items
Published on 12/05/2025 at 02:35, 2 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 9 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 36 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 19 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
